All posts tagged
An EU Project will tackle Multiple Sclerosis using Personalized Multi Omics
Interview: GeNeuro’s CFO explains its Unique Multiple Sclerosis Treatment
UPDATE: Novartis is Favoured to Win the Race for a New MS Drug
First Euronext Biotech IPO of 2016 is Swiss, and for Multiple Sclerosis!
Sanofi-Genzyme: Still successful 5 years after the acquisition?
Labiotech UG, All Rights Reserved -
Send this to friend